Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
American Association for Cancer Research

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 21 July 2000:
Vol. 289. no. 5478, pp. 368 - 369
DOI: 10.1126/science.289.5478.368
Prev | Table of Contents | Next

News of the Week

AIDS MEETING:
Companies, Donors Pledge to Close Gap in AIDS Treatment

Jon Cohen

DURBAN, SOUTH AFRICA--Although basic science and clinical research typically dominate at this biennial event, by far the most riveting sessions at the XIII International AIDS Conference here revolved around the thicket of issues that prevent poor people in sub-Saharan Africa--where a staggering 24.5 million people are estimated to be infected with HIV--from receiving the 14 anti-HIV treatments now used in wealthy countries. Pharmaceutical companies and donors last week loosed a flood of promises about removing barriers. Conference attendees welcomed the offers of help, but many stressed that much more will be needed.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Recent advances: Paediatrics.
A. Jain and M. M Davis (2001)
BMJ 322, 1469-1472
   Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)